Literature DB >> 25593348

PlasmoGEM, a database supporting a community resource for large-scale experimental genetics in malaria parasites.

Frank Schwach1, Ellen Bushell1, Ana Rita Gomes1, Burcu Anar1, Gareth Girling1, Colin Herd1, Julian C Rayner2, Oliver Billker3.   

Abstract

The Plasmodium Genetic Modification (PlasmoGEM) database (http://plasmogem.sanger.ac.uk) provides access to a resource of modular, versatile and adaptable vectors for genome modification of Plasmodium spp. parasites. PlasmoGEM currently consists of >2000 plasmids designed to modify the genome of Plasmodium berghei, a malaria parasite of rodents, which can be requested by non-profit research organisations free of charge. PlasmoGEM vectors are designed with long homology arms for efficient genome integration and carry gene specific barcodes to identify individual mutants. They can be used for a wide array of applications, including protein localisation, gene interaction studies and high-throughput genetic screens. The vector production pipeline is supported by a custom software suite that automates both the vector design process and quality control by full-length sequencing of the finished vectors. The PlasmoGEM web interface allows users to search a database of finished knock-out and gene tagging vectors, view details of their designs, download vector sequence in different formats and view available quality control data as well as suggested genotyping strategies. We also make gDNA library clones and intermediate vectors available for researchers to produce vectors for themselves.
© The Author(s) 2014. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Mesh:

Year:  2015        PMID: 25593348      PMCID: PMC4383951          DOI: 10.1093/nar/gku1143

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


INTRODUCTION

Malaria is caused by parasites of the genus Plasmodium, members of which have adapted to infect a wide range of vertebrate hosts. It remains one of the most important infectious diseases of humans, and the repeated evolution of parasites that are resistant to front-line antimalarial drugs makes the identification of new drug and vaccine targets an urgent priority. In the past two decades, experimental genetic approaches have been employed by numerous labs to analyse gene function and assess target suitability. However, while progress has been made, obstacles to systematic genetic approaches remain. Foreign DNA can be introduced by electroporation while the parasites are haploid and replicate asexually in erythrocytes. Recombination in Plasmodium is almost exclusively homologous, but even in the most tractable species, the rodent parasite P. berghei, recombination rates using conventional technologies are low (usually not exceeding 10−3) (1). The extremely high content of adenine and thymine nucleotides (>77%) poses significant additional challenges to scaling up manipulation of the genome because it renders P. berghei genomic DNA unstable in E. coli. The latter problem can be overcome in part by using a new class of low copy linear plasmid derived from phage N15 (2), which has allowed the generation of a representative genomic library covering most P. berghei genes in their entirety to be maintained in E. coli for the first time (3). We have recently established protocols that use lambda phage recombinase-mediated engineering (4,5) to convert genomic DNA clones from an arrayed library into genetic modification vectors. Due to their longer homology arms, these vectors integrate into the genome with enhanced efficiency (3,6). Since recombineering technology is robust and scalable, but not generally established in parasitology laboratories, we have initiated the Plasmodium Genetic Modification Project (PlasmoGEM), which has at its heart a production pipeline for a genome wide community resource of barcoded genetic modification vectors. Most users currently request PlasmoGEM vectors to speed up conventional small- to medium-scale gene targeting or tagging projects, but vectors can also serve as starting points for more complex conditional alleles or allelic exchange vectors (7–9). An important advantage of building a global resource is that each vector is provided with a gene-specific molecular barcode which may be used to identify individual mutants. To enable the production of thousands of genetic modification vectors, we have generated a suite of software tools that automate vector design, assign gene specific molecular barcodes, guide the vector production process in the laboratory, carry out quality control on each vector using next-generation sequencing and finally suggest strategies for genotyping genetically modified parasites. Here, we describe the software and database that support the PlasmoGEM production pipeline and that provide public access to the resource.

DESCRIPTION OF THE RESOURCE AND DATABASE

PlasmoGEM vectors provide a modular toolkit for genome manipulation

The growing PlasmoGEM resource currently consists of 1857 vectors for the deletion or disruption of P. berghei genes (covering ∼1/3 of all protein coding genes), 255 vectors for C-terminal tagging with a triple haemagglutinin (3xHA) tag, and 9113 gDNA library clones that provide partial or complete coverage of 95% of all P. berghei ANKA genes. Typical vector designs are illustrated in Figure 1. The starting material for all PlasmoGEM vectors is a gDNA library clone mapping to the target gene or its regulatory elements. Vector production proceeds in two stages (3). For knock-out vectors a region of the library clone is first replaced by a bacterial selection cassette using lambda Red-ET recombinase-mediated engineering (4,5), then the resulting intermediate plasmid is turned into a transfection vector by a Gateway recombinase reaction that exchanges the bacterial selection cassette with the final markers for selection in P. berghei. For tagging vectors, the bacterial selection marker is inserted immediately upstream of the stop codon, such that after the Gateway reaction the 3xHA tag is fused in frame to the gene of interest, followed by a generic terminator sequence from the P. berghei dhfr-ts gene (Figure 1f). While these two vector designs are now in production, the approach is adaptable, and Gateway entry clones can be built to enable the Gateway reaction to have a range of outcomes, from inserting alternate tags to creating more complex mutations such as promoter swap or allele exchange. A growing panel of Gateway entry clones for diverse protein tags are also available through the resource, and users can request intermediate vectors, of which 2107 can currently be supplied, to customise gene modification vectors according to their specific needs.
Figure 1.

Graphical overview of vector design. To produce each vector, a suitable library clone, if possible with full coverage of the gene of interest (GOI), is picked by the software (a). After adding sequence annotations to the library clone, two 50 nt homology regions are selected towards the 5' and 3' end of the GOI (recUp/recDown) for recombinase-mediated engineering. These are assembled into recombineering oligomers by adding a barcode module to recUp and the R1/R2 PCR primer 3' annealing sequences (b). A pair of quality control PCR primers (QCR1/QCR2) and a genotyping primer (GT) are also designed. The recUp/Down pair is used to amplify the bacterial selection marker cassette, thus adding the 50 nt Plasmodium genomic sequences to the cassette to drive the Red/ET recombinase mediated replacement of the GOI, which gives rise to the intermediate vector (c). A Gateway reaction swaps the bacterial for a Plasmodium selection marker cassette to produce the final transfection vector (d). The final vector is transfected into P. berghei schizonts and pyrimethamine selects for genomic integration by homologous recombination (e). For C-terminal peptide tagging designs the process is similar, except that only the stop codon of the GOI is replaced by the selection marker, which fuses a marker peptide (here a triple HA tag) to the GOI in frame (f). From the unmodified state to the final transfection vector, library clone inserts are maintained in the linear pJazz vector backbone.

Graphical overview of vector design. To produce each vector, a suitable library clone, if possible with full coverage of the gene of interest (GOI), is picked by the software (a). After adding sequence annotations to the library clone, two 50 nt homology regions are selected towards the 5' and 3' end of the GOI (recUp/recDown) for recombinase-mediated engineering. These are assembled into recombineering oligomers by adding a barcode module to recUp and the R1/R2 PCR primer 3' annealing sequences (b). A pair of quality control PCR primers (QCR1/QCR2) and a genotyping primer (GT) are also designed. The recUp/Down pair is used to amplify the bacterial selection marker cassette, thus adding the 50 nt Plasmodium genomic sequences to the cassette to drive the Red/ET recombinase mediated replacement of the GOI, which gives rise to the intermediate vector (c). A Gateway reaction swaps the bacterial for a Plasmodium selection marker cassette to produce the final transfection vector (d). The final vector is transfected into P. berghei schizonts and pyrimethamine selects for genomic integration by homologous recombination (e). For C-terminal peptide tagging designs the process is similar, except that only the stop codon of the GOI is replaced by the selection marker, which fuses a marker peptide (here a triple HA tag) to the GOI in frame (f). From the unmodified state to the final transfection vector, library clone inserts are maintained in the linear pJazz vector backbone.

The PlasmoGEM database

Public access to all PlasmoGEM resources is available at http://plasmogem.sanger.ac.uk through a web application written in the Perl Catalyst framework. To find available resources users can browse the genome or search by keywords, gene name or gene identifier. Searches can include the whole genome, or be restricted to genes for which resources are already available. Vector designs are generated using an automated approach (see below), and for each design users can drill down to a detailed data page with graphical representations and links to downloadable Genbank files for both the targeting vector and the modified target locus that will be generated upon insertion of that vector (Figure 2). Sequences of oligonucleotide primers suitable for validating the identity of the vector and for genotyping the genetically modified parasite are suggested. Different designs may have different utilities for genetic modification, and users are made aware of risks associated with particular designs. Users can drill down to quality control data from full-length deep sequencing of homology arms for up to four clones implementing any given vector design. In cases where no sequence-perfect clone was obtained, the quality control pages display graphical representations showing types and locations of any mutations to enable users to make informed choices of which clone to select.
Figure 2.

Screenshot showing a design data page of a knock-out vector for PBANKA_010510, a conserved Plasmodium protein of unknown function. Sequences of the recombineering and quality control oligomers are given and interactive genome-browser-like widgets present graphical representations of the design and the final mutated locus in the parasite genome. Fully annotated sequences of the vector designs, the intermediates and final transfection vectors can be downloaded in Genbank format from here.

Screenshot showing a design data page of a knock-out vector for PBANKA_010510, a conserved Plasmodium protein of unknown function. Sequences of the recombineering and quality control oligomers are given and interactive genome-browser-like widgets present graphical representations of the design and the final mutated locus in the parasite genome. Fully annotated sequences of the vector designs, the intermediates and final transfection vectors can be downloaded in Genbank format from here.

Automated vector design

The MySQL database that is accessed through the web interface also underpins an information management system that controls the vector production pipeline. The database is populated by a custom software suite, written in Perl, which automates vector design, sample management and quality control. The design process begins with the selection of the most suitable gDNA library clone. This is followed by annotation of all relevant genomic features including genes and putative regulatory elements, based on the P. berghei ANKA reference genome available from the GeneDB FTP page ftp://ftp.sanger.ac.uk/pub/pathogens/P_berghei/January_2011. Target sites, 50 nt in length, are then selected for recombinase-mediated engineering of the intermediate vectors and used to design two synthetic oligonucleotides for the recombineering step, one of which includes a gene specific barcode module. Clone selection is designed to increase recombination frequency by favouring library clones with long homology arms either side of the target gene. However, we noticed a sharp drop in the overall success of the production pipeline with library clone inserts above 10 kb (Supplementary Figure S1). For that reason, library clones less than 10 kb in length are preferred by the selection algorithm. Plasmodium genes have relatively few and mostly small introns, meaning that knock-out vectors can often be designed to delete the entire protein coding sequence of the target gene. However, in many vectors the deleted region is actually smaller than the complete gene, for instance when no gDNA clone provides complete coverage or to ensure homology arms are at least 1 kb long. The Plasmodium genome is relatively compact, meaning that regulatory and UTR regions can overlap between neighbouring genes. Deletion vectors are therefore designed not to interfere with 1 kb upstream and 0.8 kb downstream of neighbouring open reading frames. Data from strand-specific RNA sequencing may soon reveal the structure of individual transcripts more precisely and may allow these rules to be refined for future vector designs. The current decision tree that underpins clone selection and vector design is illustrated in Supplementary Figure S2.

Molecular barcodes

Each PlasmoGEM vector carries a molecular barcode consisting of 11 variable nucleotides flanked by constant primer annealing sites for PCR amplification. Barcodes can be used to identify individual vectors and transgenic parasites, but their main application is for quantitative analyses using barcode counting (10) on a benchtop sequencer. Analysing mixed populations of mutants in this way will enable drop out screens and will make it possible for the first time to measure individual growth rates within parasite pools composed of different mutants in the same mouse. The barcode module is included in one of the synthetic oligonucleotides used for the recombineering step of vector production. Most barcodes are gene rather than vector-specific, i.e. tagging and knock-out vectors for the same gene usually share the same barcode. They are assigned from a list of 5300 unique 11mers with a Hamming distance of at least four, i.e. sequences are unique with up to four base miscalls between any two barcodes. This level of uniqueness prevents cross contamination of barcode counts because single nucleotide changes or sequencing errors can be detected and corrected while double errors can be detected and discarded at the analysis stage. A few vectors with Hamming distances <4 were initially created and are flagged up on the vector pages of the database. A constant pair of PCR primers can be used to amplify the barcode module from all PlasmoGEM constructs.

Quality control by next-generation sequencing

The highly AT rich P. berghei genome contains many repetitive sequences and long homopolymeric tracts of adenine and thymine nucleotides that accumulate mutations at an increased rate when propagated in E. coli. Some of these could inadvertently modify neighbouring genes, if introduced into the parasite genome by the long homology arms of recombineered vectors. In the worst case (and in the absence of genetic complementation experiments) this may lead to the misattribution of a phenotype to the wrong gene. The homology arms and barcodes of vectors are therefore verified at the end of the production pipeline by sequencing four clones per design on an Illumina MiSeq instrument (150 bp paired ends are sequenced of 400–600 bp fragments (11)). This approach proved economical since production plates are laid out to eliminate overlap between homology arms of different vectors, allowing reads from a sequencing library encompassing an entire plate to be mapped back unambiguously to individual vectors. We typically sequence four colonies each from five plates together using different Illumina index codes. Read mapping and alignment processing uses open-source tools SMALT (https://www.sanger.ac.uk/resources/software/smalt/) and SAMtools (12). Mutations are called by a module of our custom software suite. Only high-quality alignments (quality score ≥ 20) within the expected insert-size range are used for the analysis. Point mutations and short insertions or deletions, which most often occur in long homopolymeric tracts of A or T nucleotides, are called when Binary Alignment/Map (BAM) files (12) reveal at least 25% of aligned reads with the mutation. Larger mutations, such as loss of a homology arm or structural rearrangements, are detected from drops of read coverage below 30% of the average depth (Figure 3).
Figure 3.

Quality control by next-generation sequencing of vector PbGEM-040545 (C-terminal tagging of PBANKA_110360, ATPase3), illustrating use of coverage to detect loss of the right homology arm in clone 1, and of sequence alignments to detect a single nucleotide deletion in the left arm and a point mutation in the right arm of clone 2.

Quality control by next-generation sequencing of vector PbGEM-040545 (C-terminal tagging of PBANKA_110360, ATPase3), illustrating use of coverage to detect loss of the right homology arm in clone 1, and of sequence alignments to detect a single nucleotide deletion in the left arm and a point mutation in the right arm of clone 2. Vectors fail quality control if they carry mutations in open reading frames of the target gene (tagging vectors) or any neighbouring gene (all vectors), regardless of whether the mutation would be synonymous or not. Mutations in the barcode module or longer deletions and rearrangements also fail quality control. Where no sequence-perfect clone is available, point mutations or small insertions/deletions in non-coding regions are tolerated and flagged in the database so that users are aware of them and can make informed choices about vector usage. Where we suspect natural deviations from the reference genome, such as occur at naturally polymorphic loci, automated quality control can be overridden by a curator.

Mutant genotyping

The vector design software integrates the Primer3 suite (13) to generate sequences for three gene-specific PCR primers for genotyping. Parameters used for primer design are shown in Supplementary Table S1. Primer pair QCR1/QCR2 (Figure 1) produces a 300–700 bp product across the intended insertion/deletion site. They are used initially to verify the identity of the library clone at the start of vector production. During genotyping of mutant parasites they serve to detect the unmodified genomic locus. Combined with constant primers annealing in the intermediate and final cassettes, QCR2 is used again to monitor the production process and to genotype transgenic parasite clones. A third primer, designated GT (for genotyping), anneals to the genomic sequence outside of the region covered by the gDNA clone. It is used in combination with one of the constant primers binding to the P. berghei selection cassette to verify the integration of the construct into the parasite genome. This PCR product is designed to span the shorter of the two homology arms.

Integration with other Databases

The availability of PlasmoGEM library clones andgene modification vectors is exported to PlasmoDB (http://plasmodb.org), the Plasmodium community database, on a daily basis and displayed on PlasmoDB gene data pages and search results. PlasmoGEM gene pages link to corresponding entries on GeneDB (http://www.genedb.org) and the Rodent Malaria genetically modified Parasites database (RMgmDB; http://www.pberghei.eu). Vice versa, RMgmDB now links back to PlasmoGEM for genetic modifications introduced by PlasmoGEM vectors. We encourage all recipients of our vectors to submit phenotypes to RMgmDB.

Availability

All data can be freely accessed via the PlasmoGEM website at http://plasmogem.sanger.ac.uk. We welcome user feedback, including requests for new vectors to be produced, by email to plasmogem@sanger.ac.uk. Materials can be requested by non-profit organisations free of charge. These include finished gene modification vectors and unmodified library clones as well as vectors required to turn wild-type clones into gene modification vectors following our published protocols (14). Details for the request procedure are available at http://plasmogem.sanger.ac.uk/request/howto.

DISCUSSION AND FUTURE PLANS

The PlasmoGEM database makes a growing resource of genetic modification vectors and design tools accessible to the research community. These can greatly reduce the time and effort needed to delete or modify parasite genes, thereby allowing researchers to apply conventional approaches to larger numbers of genes more effectively. Importantly, gene specific sequence barcodes will open up new approaches that rely on barcode counting, such as competitive growth phenotyping of multiple mutants in the same mouse. Recording phenotype data for individual vectors in the database will be a major future addition. Currently, the PlasmoGEM resource already covers about one third of all P. berghei genes with knock-out constructs. We will grow the resource further to include the vast majority of protein coding genes for which suitable genomic library clones are available, perhaps with the exception of large families of variant surface antigens. The PlasmoGEM database will be developed to accommodate a growing number of functionally diverse selection cassettes for gene deletion and 3' tagging, but we are currently focussing on gene deletion vectors for P. berghei, in part because nearly 50% of the genes in the Plasmodium genomes have no annotated function or homologue outside closely related parasite species. Importantly, the PlasmoGEM software and production pipeline can readily be pointed at other Plasmodium genomes to perform similar tasks. A key question will be how to focus future efforts, and while full genome coverage is desirable, genome-wide sets of vectors will not be possible for all construct designs and species. Community involvement in the direction and uptake of the resource will therefore be key, and we plan to adapt the website to include an online ordering system and the ability to request genes to be targeted by new PlasmoGEM vectors. In the meantime, we encourage our users to send us suggestions for new vectors via email to plasmogem@sanger.ac.uk. Community annotation of vector pages, recording which ones have been used successfully in what circumstances, would also be a useful feature, with basic phenotyping data linked through to the RMgmDB. Community-led large-scale experimental genetic projects have revolutionised the understanding of model organisms from yeast to Drosophila to mice. We hope that PlasmoGEM will serve a catalysing function for a similar community revolution in Plasmodium experimental genetics.

SUPPLEMENTARY DATA

Supplementary Data are available at NAR Online.
  13 in total

1.  Quantitative phenotyping via deep barcode sequencing.

Authors:  Andrew M Smith; Lawrence E Heisler; Joseph Mellor; Fiona Kaper; Michael J Thompson; Mark Chee; Frederick P Roth; Guri Giaever; Corey Nislow
Journal:  Genome Res       Date:  2009-07-21       Impact factor: 9.043

2.  High efficiency transfection of Plasmodium berghei facilitates novel selection procedures.

Authors:  Chris J Janse; Blandine Franke-Fayard; Gunnar R Mair; Jai Ramesar; Corinna Thiel; Sabine Engelmann; Kai Matuschewski; Geert Jan van Gemert; Robert W Sauerwein; Andrew P Waters
Journal:  Mol Biochem Parasitol       Date:  2005-10-07       Impact factor: 1.759

3.  An improved recombineering approach by adding RecA to lambda Red recombination.

Authors:  Junping Wang; Mihail Sarov; Jeanette Rientjes; Jun Fu; Heike Hollak; Harald Kranz; Wei Xie; A Francis Stewart; Youming Zhang
Journal:  Mol Biotechnol       Date:  2006-01       Impact factor: 2.695

4.  The Sequence Alignment/Map format and SAMtools.

Authors:  Heng Li; Bob Handsaker; Alec Wysoker; Tim Fennell; Jue Ruan; Nils Homer; Gabor Marth; Goncalo Abecasis; Richard Durbin
Journal:  Bioinformatics       Date:  2009-06-08       Impact factor: 6.937

5.  A new logic for DNA engineering using recombination in Escherichia coli.

Authors:  Y Zhang; F Buchholz; J P Muyrers; A F Stewart
Journal:  Nat Genet       Date:  1998-10       Impact factor: 38.330

6.  Primer3--new capabilities and interfaces.

Authors:  Andreas Untergasser; Ioana Cutcutache; Triinu Koressaar; Jian Ye; Brant C Faircloth; Maido Remm; Steven G Rozen
Journal:  Nucleic Acids Res       Date:  2012-06-22       Impact factor: 16.971

7.  A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers.

Authors:  Michael A Quail; Miriam Smith; Paul Coupland; Thomas D Otto; Simon R Harris; Thomas R Connor; Anna Bertoni; Harold P Swerdlow; Yong Gu
Journal:  BMC Genomics       Date:  2012-07-24       Impact factor: 3.969

8.  Linear plasmid vector for cloning of repetitive or unstable sequences in Escherichia coli.

Authors:  Ronald Godiska; David Mead; Vinay Dhodda; Chengcang Wu; Rebecca Hochstein; Attila Karsi; Karen Usdin; Ali Entezam; Nikolai Ravin
Journal:  Nucleic Acids Res       Date:  2009-12-29       Impact factor: 16.971

9.  Recombination-mediated genetic engineering of Plasmodium berghei DNA.

Authors:  Claudia Pfander; Burcu Anar; Mathieu Brochet; Julian C Rayner; Oliver Billker
Journal:  Methods Mol Biol       Date:  2013

10.  Phosphoinositide metabolism links cGMP-dependent protein kinase G to essential Ca²⁺ signals at key decision points in the life cycle of malaria parasites.

Authors:  Mathieu Brochet; Mark O Collins; Terry K Smith; Eloise Thompson; Sarah Sebastian; Katrin Volkmann; Frank Schwach; Lia Chappell; Ana Rita Gomes; Matthew Berriman; Julian C Rayner; David A Baker; Jyoti Choudhary; Oliver Billker
Journal:  PLoS Biol       Date:  2014-03-04       Impact factor: 8.029

View more
  38 in total

Review 1.  Advances in molecular genetic systems in malaria.

Authors:  Tania F de Koning-Ward; Paul R Gilson; Brendan S Crabb
Journal:  Nat Rev Microbiol       Date:  2015-06       Impact factor: 60.633

Review 2.  Towards genome-wide experimental genetics in the in vivo malaria model parasite Plasmodium berghei.

Authors:  Joachim M Matz; Taco W A Kooij
Journal:  Pathog Glob Health       Date:  2015-03-19       Impact factor: 2.894

3.  Evolutionarily distant I domains can functionally replace the essential ligand-binding domain of Plasmodium TRAP.

Authors:  Dennis Klug; Sarah Goellner; Jessica Kehrer; Julia Sattler; Léanne Strauss; Mirko Singer; Chafen Lu; Timothy A Springer; Friedrich Frischknecht
Journal:  Elife       Date:  2020-07-10       Impact factor: 8.140

4.  ALBA4 modulates its stage-specific interactions and specific mRNA fates during Plasmodium yoelii growth and transmission.

Authors:  Elyse E Muñoz; Kevin J Hart; Michael P Walker; Mark F Kennedy; Mackenzie M Shipley; Scott E Lindner
Journal:  Mol Microbiol       Date:  2017-08-29       Impact factor: 3.501

Review 5.  Advances in genetics and genomics: use and limitations in achieving malaria elimination goals.

Authors:  Sharmini Gunawardena; Nadira D Karunaweera
Journal:  Pathog Glob Health       Date:  2015-05       Impact factor: 2.894

6.  Ribozyme-mediated, multiplex CRISPR gene editing and CRISPR interference (CRISPRi) in rodent-infectious Plasmodium yoelii.

Authors:  Michael P Walker; Scott E Lindner
Journal:  J Biol Chem       Date:  2019-05-01       Impact factor: 5.157

7.  Genome-Scale Identification of Essential Metabolic Processes for Targeting the Plasmodium Liver Stage.

Authors:  Rebecca R Stanway; Ellen Bushell; Anush Chiappino-Pepe; Magali Roques; Theo Sanderson; Blandine Franke-Fayard; Reto Caldelari; Murielle Golomingi; Mary Nyonda; Vikash Pandey; Frank Schwach; Séverine Chevalley; Jai Ramesar; Tom Metcalf; Colin Herd; Paul-Christian Burda; Julian C Rayner; Dominique Soldati-Favre; Chris J Janse; Vassily Hatzimanikatis; Oliver Billker; Volker T Heussler
Journal:  Cell       Date:  2019-11-14       Impact factor: 41.582

8.  The 2015 Nucleic Acids Research Database Issue and molecular biology database collection.

Authors:  Michael Y Galperin; Daniel J Rigden; Xosé M Fernández-Suárez
Journal:  Nucleic Acids Res       Date:  2015-01       Impact factor: 16.971

9.  GeneTargeter: Automated In Silico Design for Genome Editing in the Malaria Parasite, Plasmodium falciparum.

Authors:  Pablo Cárdenas; Lisl Y Esherick; Gaël Chambonnier; Sumanta Dey; Christopher V Turlo; Armiyaw Sebastian Nasamu; Jacquin C Niles
Journal:  CRISPR J       Date:  2022-02

Review 10.  Essential Genes of the Parasitic Apicomplexa.

Authors:  Jenna Oberstaller; Thomas D Otto; Julian C Rayner; John H Adams
Journal:  Trends Parasitol       Date:  2021-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.